Metabolomics Panel Associated with Cystic Fibrosis-Related Diabetes toward Biomarker Discovery-Reference-Cited by-同舟云学术

Metabolomics Panel Associated with Cystic Fibrosis-Related Diabetes toward Biomarker Discovery

Published:2024-07-16 Issue: Volume: Page:
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Mujammami Muhammad¹²,Nimer Refat M.³,Al Mogren Maha⁴,Almalki Reem⁴^ORCID,Alabdaljabar Mohamad S.⁵,Benabdelkamel Hicham⁶,Abdel Rahman Anas M.⁴⁷^ORCID

Affiliation:

1. Endocrinology and Diabetes Unit, Department of Medicine, College of Medicine, King Saud University, Riyadh 12372, Saudi Arabia

2. Diabetes University Center, King Saud University Medical City, King Saud University, Riyadh 12372, Saudi Arabia

3. Department of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan

4. Metabolomics Section, Department of Clinical Genomics, Center for Genomics Medicine, King Faisal Specialist Hospital and Research Centre (KFSHRC), Riyadh 11211, Saudi Arabia

5. Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, United States

6. Proteomics Resource Unit, Obesity Research Center, College of Medicine, King Saud University, Riyadh 11362, Saudi Arabia

7. Department of Biochemistry and Molecular Medicine, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia

Funder

King Saud University

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.4c03626

Reference40 articles.

1. Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA

2. Cystic Fibrosis Mutation database. Cystic fibrosis mutation database 2021, http://www.genet.sickkids.on.ca/StatisticsPage.html.

3. (CFTR2) CaFToC. Clinical and Functional TRanslation of CFTR (CFTR2), 2023, http://cftr2.org.

4. Epidemiology, Pathophysiology, and Prognostic Implications of Cystic Fibrosis–Related Diabetes

5. Pancreatic pathophysiology in cystic fibrosis